Purpose: To test the use of Intensity Modulated Radiotherapy (IMRT) to spare the bone marrow (BM) in patients treated with cancer cervix through using the bone marrow an organ at risk. Patients and methods: Thirteen patients with stage (IB2-IIIB) intact cervix cancer were included; C-T simulation was done with contrast and full bladder with slice thickness 2.5 mm. Clinical Target Volume (CTV) included the cervix, uterus, upper half of the vagina, parametrium and regional lymph nodes. The CTV was expanded by 1 cm to form the Planning Target Volume (PTV). The organ at risk (OAR) included the bladder and rectum, the external contour of the pelvic bones to define the Pelvic Bone Marrow (PBM). Four plans were done for every patient with anteroposterior-posteroanterior (AP/PA), three dimensional conformal radiotherapy (3DCRT), IMRT, bone marrow-sparing intensity-modulated pelvic radiotherapy (BMS-IMRT). Results: BMS-IMRT reduced the V20, V30, V40 and V45 of the BM in comparison to 3DCRT and IMRT plans. Reduction in V20 with BMS-IMRT plan compared to 3DCRT (p < 0.03). The PBM volume receiving 5, 10 and 20 Gy was lower AP/PA than BMS-IMRT (p < 0.01, p < 0.001 and p < 0.04 respectively). The volumes of the rectum and bladder receiving dose of 40 and 45 Gy were lower in BMS-IMRT plan compared to AP/PA and 3DCRT plans with p = 0.01 for both of them. PTV cover was better in the BMS-IMRT and IMRT plans. Conclusion: BMS-IMRT decreased the irradiated BM volume compared to other techniques. Thus using BMS-IMRT is recommended to decrease hematological toxicity and avoid 
Introduction
Concurrent chemo-radiotherapy is the standard treatment practice for locally advanced cancer cervix. Randomized trials have found that chemoradiation therapy improves tumor control compared with radiation therapy (RT) alone [1] [2] also it is more effective in improving survival than radiotherapy alone.
On the other hand, hematologic toxicity from the combined treatment, results in delaying chemotherapy courses, which affect the treatment outcome [3] .
Thus, it is important to decrease the incidence of acute hematologic toxicity so as to tolerate the treatment.
The lumbar, sacrum, iliac crest, ischium, pubis, and proximal femur, produces about 50% of the bone marrow [4] and these regions are exposed to various dose of radiation throughout the course of external beam radiotherapy.
Together radiation and chemotherapy are myelosuppressive, however the degree and mechanism by which radiation causes haematologic toxicity with chemotherapy are still unknown. Radiation leads to apoptosis of bone marrow (BM) stem cells and stromal damage, leading to myelosuppression of bone marrow [5] .
Studies showed that the degree of bone marrow injury caused by radiation is dependent on volume of the bone marrow irradiated as well as the dose received by the bone marrow [6] [7] . Pelvic irradiation involves large volumes of active BM.
In this study, our aim is to make the BM as organ at risk in the so as to reduce the irradiated bone marrow volume in cases treated for cancer cervix.
Patients and Methods

Patients
Thirteen cervical cancer patients who were treated with concurrent chemotherapy-radiotherapy were included in the study. The mean and median age was 53.5 and 52 respectively. All patients were with intact cervix, with FIGO (International Federation of Gynecology and Obstetrics) stage IB2 in 2, IIB in 8, IIIA in 2 and IIIB IN 1.
Patients with early stages, stage IVA and IVB and postoperative cases were excluded from the study.
Simulation
This is a dosimetric study where C-T simulation was done for thirteen patients with cervix cancer with contrast and full bladder using GE-CT simulator with a All plans were normalized to cover 98% of the PTV. All treatment plans are evaluated using isodose line distribution and dose-volume histogram (DVH).
The PBM total (which include iliac, pubis and Lumbosacral) and OAR volumes irradiated at different dose 5, 10, 20, 30, 40 and 45 Gy was compared. The analysis was performed as mean ± SD using Origin 6. P value < 0.05 is significant.
Results
The 3DCRT technique. The AP/PA plans produced sharp fall-off in isodose lines, 3DCRT plans showed better dose coverage to the PTV than AP/PA techniques, however 3DCRT plans showed that there is a greater dose to the PBM. and V45) with AP/PA techniques, but the differences were not statistically significant (p < 0.33, p < 0. 08 and p < 0.18 respectively).
There is a significant reduction in BMS-IMRT included iliac bone marrow V10 and V20 compared with AP/PA (p < 0.03). 
Discussion
Great concern has been raised for the use of IMRT in patients with gynecologic malignancies. IMRT reduced the volume of small bowel, bladder, and rectum irradiated in cases with cervical and endometrial cancers in comparison to conventional whole pelvic radiotherapy [8] [9] [10] [11] .
In the present study, BMS-IMRT was superior in reducing the BM volume (V20, V30, V40, V45) compared with 3DCRT and IMRT.
The V5, V10 and V20 of the PBM were lower with AP/PA than BMS-IMRT (p < 0.01, p < 0.001 and p < 0.04 respectively). Brixey et al. [12] reported that hematological toxicity was minimized by using
IMRT plan compared to four-field box. The dose to Iliac, lumbar, and sacral BM were also reduced with IMRT, although the aim was not planned to spare the BM.
Lujan et al 2003 [13] , reported that BMS IM-WPRT treatment plans demonstrated a significant reduction of the volume of BM receiving > 40% (18 Gy) of the prescription dose (45 Gy) compared to both IM-WPRT and four-field treatment.
Wong et al 2005 [14] , used an intensity-modulated arc therapy (IMAT) for treating patients with endometrial cancer. Results showed that using two anterior intensity-modulated arcs produced good cover for the PTVs. Also; IMAT technique allowed sparing of the iliac similar to 8-field IMRT. But the 8-field
IMRT resulted in better dose uniformity than IMAT in the target volumes coverage.
Regarding postoperative cervical cancer patients, Chen et al. [15] , demonstrated that using IMRT reduced PBM irradiation compared with four-field box techniques.
Ahmed et al 2004 [16] , studied the feasibility of dose escalation to para-aortic lymph node (PALN) through using intensity modulated radiation therapy 
